Drugmakers are trying to win drug approvals by parsing vast data sets of electronic medical records, shifting away from lengthy, and costly, clinical trials in patients.

Pfizer Inc., Johnson & Johnson and Amgen Inc. are among the drugmakers that have submitted the data-mining analyses to the U.S. Food and Drug Administration in seeking…

Read More